P04-34. Identification of 4E10-like antibodies in plasma of an HIV-1 CRF02_AG infected patient with broad neutralizing activity using peptide phage libraries

by Heyndrickx L, Willems B, Dieltjens T, Vanham G
Published 2009-10-01

P04-14. Sequential HIV-1 isolates from infected individuals reveals emergence of neutralization sensitive HIV-1 strains in the course of infection

by Gorny MK, Vanham G, Heyndrickx L, Williams C, Burda S, Nyambi PN
Published 2009-10-01

P12-11. Resistance to the CD4 mimetic mini protein M48-U1 induces changes in a highly conserved region on the HIV-1 gp120 envelope protein

by Martin L, Martin G, Michiels J, Heyndrickx L, Grupping K, Vanham G
Published 2009-10-01

P18-08. Characterization of CD34+ derived dendritic cells generated <it>in vitro </it>and transfected with HIV gene as potential therapeutic vaccine in macaque

by Le Grand R, Vanham G, Banchereau J, Van Gulck E, Zurawski G, Romain G, Martinon F
Published 2009-10-01

P04-52 LB. The importance of well-defined HIV-1 neutralization assays

by Lanzavecchia A, Corti D, Davis D, Heyndrickx L, Vereecken K, Willems B, Balla-Jhagjhoorsingh SS, Weiss R, Vanham G
Published 2009-10-01

Nef interferes with development of thymic T cell precursors: differential mechanisms in HIV and SIV

by Kirchhoff F, Fackler OT, Vanham G, Taghon T, Vanderstraeten H, Naessens E, Vandewalle I, Ariën KK, Meuwissen PJ, Saksela K, Verhasselt B
Published 2011-10-01

P04-11. Prevalence of neutralizing antibody responses in chronic clades A and D human immunodeficiency virus type 1 (HIV-1) infections

by Grosskurth H, Kamali A, Maher D, Levin J, Vanham G, Balla S, Montefiori D, Sokolik-Wolak B, Tomusange K, Njai HF, Pala P, Kaleebu P
Published 2009-10-01

Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization

by Heyndrickx L, Stewart-Jones G, Schuitemaker H, Bowles E, Buonaguro L, Jansson M, Grevstad B, Vinner L, Ramaswamy M, Biswas P, Scarlatti G, Vanham G, Fomsgaard A
Published 2012-09-01